Carregant...

A dominant inhibitory mutant of the type II transforming growth factor beta receptor in the malignant progression of a cutaneous T-cell lymphoma.

In many cancers, inactivating mutations in both alleles of the transforming growth factor beta (TGF-beta) type 11 receptor (TbetaRII) gene occur and correlate with loss of sensitivity to TGF-beta. Here we describe a novel mechanism for loss of sensitivity to growth inhibition by TGF-beta in tumor de...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Knaus, P I, Lindemann, D, DeCoteau, J F, Perlman, R, Yankelev, H, Hille, M, Kadin, M E, Lodish, H F
Format: Artigo
Idioma:Inglês
Publicat: 1996
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC231343/
https://ncbi.nlm.nih.gov/pubmed/8668164
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!